Lateralized response of oxytocinase activity in the medial prefrontal cortex of a unilateral rat model of Parkinson's disease

Behavioural Brain Research

Volumn 213, Issue 2, 2010, Pages 328-331

  Banegas, Inmaculada ^a   Prieto, Isabel ^a   Vives, Francisco ^b   Alba, Francisco ^b   de Gasparo, Marc ^c   Duran, Raquel ^b   Segarra, Ana Belen ^a   Ramírez, Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c NONE   (Switzerland)

Author keywords

Brain asymmetry; Dopamine; Hemi parkinsonism; IRAP; Vasopressinase

Indexed keywords

CYSTYL AMINOPEPTIDASE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME SUBSTRATE; HYDROLYSIS; MALE; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SUBSTANTIA NIGRA; ANIMAL; DISEASE MODEL; ENZYMOLOGY; HEMISPHERIC DOMINANCE; METABOLISM; WISTAR RAT;

ANIMALS; CYSTINYL AMINOPEPTIDASE; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; MALE; OXIDOPAMINE; PARKINSON DISEASE; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 77953914748     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.05.030     Document Type: Article

References (26)

1. Albiston A.L., Mcdowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., et al. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001, 276:48623-48626.
2. Banegas I., Prieto I., Alba F., Vives F., Araque A., Segarra A.B., et al. Angiotensinase activity is asymmetrically distributed in the amygdala, hippocampus and prefrontal cortex of the rat. Behav Brain Res 2005, 156:321-326.
3. Banegas I., Barrero F., Durán R., Morales B., Luna J.D., Prieto I., et al. Plasma aminopeptidase activities in Parkinson's disease. Horm Metab Res 2006, 38:758-760.
4. Banegas I., Prieto I., Vives F., Alba F., de Gasparo M., Duran R., et al. Asymmetrical response of aminopeptidase A and nitric oxide in plasma of normotensive and hypertensive rats with experimental hemiparkinsonism. Neuropharmacology 2009, 56:573-579.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976, 72:248-254.
6. Brück A., Kurki T., Kaasinen V., Vahlberg T., Rinne J.O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 2004, 75:1467-1469.
7. Chai S.Y., Yeatman H.R., Parker M.W., Ascher D.B., Thompson P.E., Mulvey H.T., et al. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase. BMC Neurosci 2008, 9:S14.
8. Cubo E., Martin P.M., Martin-Gonzalez J.A., Rodriguez-Blazquez C., Kulisevsky J. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord 2010, 25:70-75. ELEP Group Members.
9. Djaldetti R., Ziv I., Melamed E. The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 2006, 5:796-802.
10. Farina E., Cappa S.F., Polimeni M., Magni E., Canesi M., Zecchinelli A., et al. Frontal dysfunction in early Parkinson's disease. Acta Neurol Scand 1994, 90:34-38.
11. Fernando R.N., Larm J., Albiston A.L., Chai S.Y. Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system. J Comp Neurol 2005, 487:372-390.
12. Gard P.R. Cognitive-enhancing effects of angiotensin IV. BMC Neurosci 2008, 9:S15.
13. Gülpinar M.A., Yegen B.C. The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci 2004, 5:457-473.
14. Henderson J.M., Watson S., Halliday G.M., Heinemann T., Gerlach M. Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. Behav Brain Res 2003, 139:105-113.
15. Jolicoeur F.B., Rivest R. Rodent model of Parkinson's disease. Neuromethods 21, animal models of neurological disease I 1992, 135-158. Humana Press, Totowa, NJ. A.A. Boulto, G.B. Bakerand a, R.F. Butterworth (Eds.).
16. Lang A.E., Obeso J.A. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004, 3:309-316.
17. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, London. 4th ed.
18. Ramírez M., Prieto I., Vives F., de Gasparo M., Alba F. Neuropeptides, neuropeptidases and brain asymmetry. Curr Protein Pept Sci 2004, 5:497-506.
19. Stragier B., De Bundel D., Sarre S., Smolders I., Vauquelin G., Dupont A., et al. Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin. IV. A review. Heart Fail Rev 2008, 13:321-337.
20. Sullivan R.M. Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine. Stress 2004, 7:131-143.
21. Taylor A.E., Saint-Cyr J.A., Lang A.E. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 1986, 109:845-883.
22. Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H., Tomoda Y. Identification of human placental leucine aminopeptidase as oxytocinase. Arch Biochem Biophys 1992, 292:388-392.
23. Tzschentke T.M. The medial prefrontal cortex as a part of the brain reward system. Amino Acids 2000, 19:211-219.
24. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1971, 367:95-122.
25. Veenema A.H., Neumann I.D. Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res 2008, 170:261-276.
26. Zgaljardic D.J., Borod J.C., Foldi N.S., Mattis P.J., Gordon M.F., Feigin A., et al. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol 2006, 28:1127-1144.